17 Dec 2019 - Following positive leads from US markets, the ASX looks set to open higher. The partial trade deal between the US and China saw global share markets rise overnight. Tech and healthcare led the way in the US. Keytone Dairy (ASX:KTD) has completed the integration project between the two powder manufacturing facilities.
17 Dec 2019 - Integrated Payment Technologies (ASX:IP1) CEO, Dean Martin discusses its payments solutions ClickSuper and PayVu, industry tailwinds, new features and platform integration.
17 Dec 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the funding package and resumption plan for the Granville Tin Project and plans for Granville to be a foundation asset in a proposed IPO.
17 Dec 2019 - Air New Zealand (ASX:AIZ) reports that Former Prime Minister of New Zealand Sir John Key will retire from its Board of Directors in March.
17 Dec 2019 - Afterpay (ASX:APT) plans to update the Afterpay US 2018 Equity Incentive Plan to offer options which give eligible participants a right to acquire common stock.
16 Dec 2019 - It has been a huge day of trade for the ASX seeing its biggest one day gain since February. After rising at the open it continued to climb closing 1.6% higher. Nearmap (ASX:NEA) is now the biggest gainer. PolyNovo (ASX:PNV) has supplied NovoSorb BTM for dermal repair after the volcano eruption New Zealand.
16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
16 Dec 2019 - Openpay Group (ASX:OPY) CEO & MD, Michael Eidel talks about its business model, size of the opportunity and how it differentiates itself from other buy now pay later (BNPL) providers.
16 Dec 2019 - The ASX has risen at the open following some small positive leads from Wall Street. It is now tracking 1.2% higher at noon. On Friday US and Chinese officials announced they had finally agreed to the phase one agreement after an 18-month trade war. Starpharma (ASX:SPL) has received a $4.9 million R&D tax incentive refund for the 2019 Financial Year.
16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what investors can expect over the next 6 months.
